Selected 2001 Venture Capital Transactions as Company Counsel

Selected 2001 Venture Capital Transactions as Company Counsel

Publication

In 2001, we served as company counsel in more than 150 venture financings raising more than $3 billion. The following are selected highlights from our 2001 transactions:

  • Achillion Pharmaceuticals — $41 million
  • Aegis Semiconductor — $16.2 million
  • Airvana — $29.5 million
  • Aplion Networks — $30 million
  • Ardais — $36 million
  • Business Layers — $25 million
  • Cerylion — $5.1 million
  • ChannelWave Software — $29 million
  • CoreChange — $36 million
  • deNovis — $43.8 million
  • Digital 5 — $12 million
  • Ellacoya Networks — $25 million
  • EM4 Photonics — $$16 million
  • Encompys — $50 million
  • Endeca Technologies — $15 million
  • First Genetic Trust — $14.3 million
  • Globalware Solutions — $30 million
  • GoldK — $36.8 million
  • InfiniSwitch—$26 million
  • Infinity Pharmaceuticals — $12.2 million
  • InteQ — $57 million
  • Nantero — $6 million
  • netDecide — $9.2 million
  • NitroMed — $31.4 million
  • Novirio Pharmaceuticals — $44 million
  • PharMetrics — $11 million
  • PhotonEx — $90 million
  • Polychromix — $7.1 million
  • Princeton eCom — $35.5 million
  • Quallaby — $14.5 million
  • Sandgate Systems — $10 million
  • Starent Networks — $22 million
  • Storability — $30 million
  • TargetRx — $10 million
  • Telica — $60 million
  • Torrent Systems — $12 million
  • TruSecure — $22 million
  • Village Ventures — $50.9 million
  • VistaPrint.com — $12.3 million
  • WaterCove Networks — $40 million
  • Winphoria Networks — $42 million
  • yet2.com — $20 million

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.